Gummies in India: Complete 2026 Guide to Vijaya Extract & Hemp Edibles

Gummies in India have quietly transformed from a niche curiosity into one of the country's fastest-growing wellness formats. Whether you are looking for Vijaya Leaf Extract gummies for pain and sleep, broad-spectrum CBD gummies for anxiety, or hemp-derived wellness edibles, the Indian market in 2026 offers a surprisingly rich — and legally compliant — landscape. This complete guide covers everything: what gummies are available in India, how to verify their legality under the NDPS Act and AYUSH regulations, how they work inside your body, dosage guidance, top brands and where to buy safely online.

What Are Gummies in India — And Why Has the Format Exploded?

A gummy, in its simplest form, is a chewable, gelatin- or pectin-based edible that carries a measured dose of an active ingredient — CBD, Vijaya Extract (cannabis leaf extract), hemp seed oil, melatonin, or Ayurvedic botanicals — in a precise, palatable format. Unlike loose powders or oil tinctures, each gummy contains a fixed dose, making it far easier for first-time users to titrate their intake.

India's interest in gummies has grown for three converging reasons: a decades-long cultural familiarity with cannabis as a traditional Ayurvedic herb (Vijaya, Bhang, Siddhis), a growing urban middle class curious about evidence-backed natural wellness, and the Ministry of AYUSH's progressive stance on Vijaya Leaf Extract as a licensed Ayurvedic Proprietary Medicine. The result is a market segment that barely existed in 2020 but commands substantial search volume and real consumer demand in 2026.

You can now buy legally manufactured gummies and edibles in India with a CoA (Certificate of Analysis) from an NABL-accredited laboratory, clear AYUSH manufacturer licensing, and verified THC levels below 0.3% — all delivered to your door.

Legal Status of Gummies in India: The NDPS Act, AYUSH Framework and 2026 Updates

Understanding the legal landscape is essential before buying any cannabis-derived product in India. Here is what the law actually says.

NDPS Act, 1985 — what is actually prohibited: The Narcotic Drugs and Psychotropic Substances Act prohibits cannabis resin (charas) and cannabis flowers/bud (ganja). Section 2(iii) of the NDPS Act explicitly excludes the leaves and seeds of Cannabis Sativa Linn from the definition of cannabis as a prohibited substance. Vijaya Leaf Extract — derived from the leaves, not the flower — therefore falls outside the NDPS prohibition.

AYUSH licensing pathway: The Ministry of AYUSH grants manufacturing licences for Ayurvedic Proprietary Medicines containing Vijaya (Cannabis Sativa) leaf extract under Schedule E-1 of the Drugs and Cosmetics Act. A gummy manufactured under this licence is a lawful Ayurvedic medicine, not a controlled substance — provided it contains no more than 0.3% THC and bears a valid AYUSH licence number on its label.

FSSAI hemp food notification (November 2021): Hemp seeds, hemp seed oil, and hemp seed flour are now approved food ingredients under the Food Safety and Standards Authority of India notification. This separately covers hemp gummies that do not contain cannabis leaf extracts but are based on hemp seeds or oil.

2026 policy update — Delhi HC directive: The Delhi High Court instructed the Union government in 2026 to consult scientific, medical, and civil society stakeholders on potential relaxation of NDPS Act restrictions, with a policy response required by July 2026. While no legislative change has been enacted yet, the directive signals active policy evolution and positions AYUSH-licensed Vijaya brands firmly within a trajectory toward broader legal access.

Bottom line for buyers: Vijaya Extract gummies with a valid AYUSH licence number, THC no more than 0.3%, and a CoA from an NABL-accredited lab are legal in India. Browse AYUSH-licensed Vijaya Extract products on THC Store, all with published lab reports.

Types of Gummies Available in India: A Category Breakdown

Not all gummies in India are the same. Here are the main categories you will encounter, and what distinguishes each.

Vijaya Extract Gummies (Cannabis Leaf Extract)

These are the premium tier — gummies made with AYUSH-licensed Vijaya Leaf Extract (also called cannabis leaf extract or full-spectrum cannabis extract). They contain a full profile of cannabinoids including CBD, THC (no more than 0.3%), CBG, terpenes and other Ayurvedically active compounds. The entourage effect — where cannabinoids and terpenes work synergistically — is strongest in this format. Read our full Vijaya Extract science guide for the clinical evidence base.

CBD-Only (Isolate or Broad-Spectrum) Gummies

CBD isolate gummies contain pure cannabidiol with 0% THC — appealing to buyers who want CBD effects without any THC, even trace amounts. Broad-spectrum CBD gummies retain other cannabinoids and terpenes but have THC removed. Both categories are available in India under AYUSH licensing. They are well-suited for anxiety, sleep support, and mild pain management.

Hemp Wellness Gummies

Hemp-derived gummies use hemp seed oil, hemp protein or hemp-derived CBD as the active ingredient. These fall under FSSAI hemp food notification rather than the AYUSH Vijaya framework, making them more accessible in general wellness retail. They are lowest in cannabinoid potency but excellent as a daily supplement baseline.

Ayurvedic Botanical Gummies

A growing category blends Vijaya Extract with classical Ayurvedic herbs — ashwagandha, brahmi, shatavari, trikatu, guduchi — for targeted formulations covering stress, sleep, immunity, and women's health. These lean most explicitly into India's traditional medicine system and resonate strongly with AYUSH-aware consumers. Explore the Ayurvedic cannabis tradition to understand this heritage.

How Gummies Work Inside Your Body: Bioavailability Science Explained

When you eat a gummy, its active compounds must survive digestion, cross the intestinal wall, and reach your bloodstream — a journey considerably more complex than an inhalation route. This is why understanding how edible gummies work matters for first-time users.

First-pass metabolism: Orally ingested CBD and other cannabinoids are processed by the liver before entering circulation (hepatic first-pass metabolism). This substantially reduces the fraction of the dose that reaches the bloodstream. Standard capsule bioavailability of CBD is estimated at 6 to 19 percent. However, modern gummy formulations using lipid-nano encapsulation (nanoemulsion or self-nanoemulsifying drug delivery systems, SNEDDS) have demonstrated meaningfully higher absorption. A 2025 crossover human trial (PMC12166629) confirmed that SNEDDS formulations produced significantly greater cannabinoid exposure compared to plain oil-based products.

Onset time: Because of the digestion step, gummies typically take 30 to 90 minutes to produce their full effect, versus 15 to 30 minutes for sublingual tinctures and near-instant effects from inhalation. The onset window varies with stomach contents, individual metabolism, and body composition.

Duration: Gummies provide longer-lasting effects — typically 4 to 8 hours — compared to inhalation (1 to 3 hours). This extended duration makes them particularly suitable for sleep support, chronic pain management, or all-day anxiety relief where consistent steady-state exposure is the goal.

If you have questions about which format is best for your specific health goals, consult one of our licensed doctors for personalised guidance before starting.

Vijaya Extract Gummies for Sleep: What the Clinical Evidence Shows

Sleep is the most common reason Indian consumers reach for cannabis-derived products. A 2019 case series published in PMC (PMC6326553) followed 72 adults with anxiety and poor sleep over three months: 66.7 percent reported improved sleep scores in the first month, with effects largely sustained at months two and three with minimal adverse events. A 2024 scoping review (PMC12695116) of cannabinoids and sleep concluded that CBD may reduce anxiety-driven sleep disruption and improve subjective sleep quality, particularly in populations where anxiety is the primary driver of insomnia.

For sleep-specific gummies in India, look for formulations combining Vijaya Extract with melatonin (the natural sleep hormone) or classical Ayurvedic sleep herbs like jatamansi and ashwagandha. A fixed bedtime dose of 10 to 25mg of CBD equivalent, taken 30 to 60 minutes before sleep, is the most common starting protocol in clinical literature — though individual response varies considerably. A doctor consultation is advisable before using gummies for diagnosed sleep disorders or when combining with existing sleep medications.

Vijaya Extract Gummies for Anxiety and Stress Relief

Anxiety is India's second most common reason for seeking cannabis wellness products. A 2024 meta-analysis (PMC11595441) of CBD for anxiety found statistically significant reductions in anxiety scores across multiple validated instruments — GAD-7, HAM-A, DASS-21 — in trials ranging from 4 to 12 weeks. The proposed mechanism is CBD's partial agonism at 5-HT1A serotonin receptors and modulation of the endocannabinoid system's stress-response pathway.

India-specific context: the AYUSH framework has been moving toward recognizing Vijaya Extract as an adaptogen — a class of substances that help the body resist physical and psychological stressors. Several AYUSH-licensed products now explicitly position Vijaya Leaf Extract alongside classical Ayurvedic adaptogens like ashwagandha and brahmi. Read the full anxiety and Vijaya Extract clinical guide for a deep-dive into the evidence.

If you are using gummies for anxiety management, start with a low dose of 5 to 10mg CBD equivalent, observe your response for 5 to 7 days before adjusting, and avoid combining with benzodiazepines or other CNS depressants without medical guidance. Our licensed doctors can review your current medications and recommend a safe starting protocol.

Vijaya Extract Gummies for Pain and Inflammation Management

Pain relief — particularly chronic musculoskeletal pain, neuropathic pain, and inflammatory joint pain — is the third major use case driving gummy adoption in India. A 2024 analgesic review (PMC11597428) confirmed that CBD acts via multiple pain pathways: transient receptor potential channels, vanilloid receptors (TRPV1), and modulation of inflammatory cytokines. Full-spectrum Vijaya Extract products add THC's analgesic contribution and the terpene beta-caryophyllene's documented CB2 agonism, which has direct anti-inflammatory mechanism.

For pain management, higher-dose gummies — 25 to 50mg CBD equivalent — are more commonly used in clinical settings. The NDPS Act's 0.3% THC cap means even full-spectrum Indian Vijaya Extract gummies operate at very low THC doses, meaning users seeking primarily CBD's analgesic effects without psychoactivity are well served by this regulatory ceiling. Explore Vijaya Leaf's pain relief benefits in depth.

Gummies vs. Oils vs. Capsules: Which Format Is Right for You?

Many Indian consumers wonder whether to choose a gummy, an oil tincture, or a capsule. Each has distinct advantages. The table below summarises the key decision points.

Factor	Gummies	Oil Tincture	Capsules and Tablets
Onset time	30 to 90 minutes	15 to 45 minutes (sublingual)	30 to 90 minutes
Duration	4 to 8 hours	3 to 6 hours	4 to 8 hours
Dose precision	Fixed per gummy	Adjustable by drops	Fixed per capsule
Taste	Flavoured and palatable	Earthy or herbal hemp taste	Tasteless
Discreetness	High — looks like candy	Moderate — dropper bottle	High — standard pill
Best for	Sleep, sustained anxiety, all-day pain	Flexible dosing and acute needs	Travel and daily supplementation
Price range in India	Rs 1,500 to Rs 5,000 per pack	Rs 1,000 to Rs 9,000 per bottle	Rs 200 to Rs 5,000 per pack

Dosage Guide for Gummies in India: How to Start Safely

Dosing cannabis-derived gummies is highly individual — body weight, metabolism, prior cannabis exposure, liver enzyme activity, and the specific condition being addressed all influence the effective dose. That said, clinical literature and product guidelines converge on several broadly applicable starting principles.

The Start Low Go Slow protocol:

• Week 1 — Calibration: Begin with 5 to 10mg CBD equivalent once daily, ideally in the evening to allow sleep to provide the first feedback signal. Do not escalate for at least 5 days.
• Week 2 to 3 — Titration: If you experience no adverse effects such as drowsiness, digestive discomfort, or dry mouth, and you have insufficient therapeutic effect, increase by 5 to 10mg increments every 5 to 7 days until target response is achieved.
• Maintenance: Most adults find their effective range between 15 and 50mg CBD-equivalent per day. Doses above 50mg should be discussed with a healthcare professional.

Age considerations: Seniors aged 65 and above often respond at the lower end of the range due to slower hepatic clearance. Young adults aged 18 to 35 may require higher doses for comparable effect. Gummies are not recommended for anyone under 18.

Food interactions: Take gummies with or after a meal containing healthy fats — avocado, full-fat dairy, ghee, coconut oil, or nuts. CBD and other cannabinoids are highly lipophilic; dietary fat substantially increases absorption, often by 4 to 6 times compared to a fasted state.

For personalised dosage advice that accounts for your health history and any concurrent medications, book a telemedicine consultation with our licensed doctor panel. Dosage guidance from a physician is especially important if you have liver conditions, take blood thinners, or use psychiatric medications.

What to Look for When Buying Gummies in India: A 7-Point Checklist

The Indian gummy market in 2026 includes both AYUSH-licensed, lab-tested products and unverified imports. Here is how to distinguish the two.

1. AYUSH manufacturing licence number on the label: Look for Lic. No. with an AYUSH state licensing authority code. No licence number means not legally manufactured as an Ayurvedic medicine.
2. CoA from an NABL-accredited laboratory: The Certificate of Analysis must show cannabinoid potency — CBD, THC, CBG and others — from an independent NABL or ISO 17025 accredited lab. THC must be no more than 0.3%.
3. Third-party, not in-house, testing: The CoA should be from a lab independent of the manufacturer. In-house testing is not an adequate quality assurance standard.
4. Batch-specific CoA, not generic brand-level report: Each production batch may vary; the CoA should match the batch number on the product packaging.
5. Clear ingredients list with no undisclosed excipients: Know exactly what is in the gummy besides the active ingredient — pectin vs. gelatin for vegan vs. non-vegan, natural vs. artificial flavours, sugar content.
6. Declared CBD or THC content per gummy, not just per pack: A pack labelled 300mg across 30 gummies means 10mg per gummy. Make sure the per-unit dose is stated clearly, not hidden in per-pack totals.
7. Trusted distributor with return and complaint policy: Buy from verified AYUSH retailers like THC Store where products are curated for licence and lab compliance. Avoid unverified social media sellers.

THC Store lists each product's AYUSH licence status and links to the brand's CoA. All Vijaya Extract products on the platform have been reviewed for regulatory compliance before listing. Explore our full Vijaya Leaf Extract collection.

Top Gummy and Cannabis Edible Brands in India (2026)

Several AYUSH-licensed brands are now producing high-quality gummies and edibles in India. Here is an overview of the leading names and what distinguishes each.

Medicann: One of India's first AYUSH-licensed cannabis medicine manufacturers. Their Cannabis Leaf Extract gummies at 350mg per pack are among the strongest gummy products available at retail, with NABL lab reports. Well-suited for moderate to high need users such as those managing chronic pain or seeking supportive care. See our complete cannabis gummies India guide.

CannaBlithe: A science-forward brand offering precision-dosed tinctures at CBD-to-THC ratios from 1:1 to 20:1. While tinctures rather than gummies, they pair well with gummy regimens for acute supplement needs. Read our full-spectrum CBD-THC India guide for context on ratio formulations.

Cannavedic: AYUSH-certified Ayurvedic brand specialising in balanced THC-CBD ratio formulations. Their CannaMild 1:5 THC-to-CBD oil is popular among patients with pain and anxiety who want a calming rather than stimulating effect. See our Ayurvedic cannabis brands overview.

Placidiol NanoLipid: A nano-encapsulated pure CBD product bridging pharmaceutical precision and wellness accessibility. The NanoLipid delivery system is the closest retail product in India to the SNEDDS formulations validated in 2025 bioavailability research. For users who want maximum CBD absorption with minimum dose, this is the premium tier.

Namaste Organics: A wellness-focused brand with stress and pain formulations including herbal blends. Their products are well-positioned for AYUSH-aware buyers looking for Ayurvedic botanical combinations alongside cannabinoids.

HEMPBUTI: One of India's established hemp brands offering AYUSH-compliant topical and supplement products. Particularly known for their hemp-based pain management range, their balm and oil formulations complement oral gummy regimens.

Where to Buy Gummies in India: Online vs. Offline

The safest and most convenient way to buy AYUSH-licensed gummies in India in 2026 is through a verified online platform. Here is why online outperforms offline for this category.

Online advantages: Access to the full catalogue of AYUSH-licensed brands, direct links to CoA documentation, home delivery with discreet packaging, customer support for compliance questions, and — on platforms like THC Store — integrated telemedicine for pre-purchase doctor consultations. Our complete guide to online cannabis ordering in India walks through the process step by step.

Offline challenges: Physical pharmacies rarely stock AYUSH Vijaya products. General wellness stores carry hemp gummies but often lack CoA documentation. The offline channel cannot match the compliance traceability the online AYUSH-licensed market provides in 2026.

Delivery across India: THC Store delivers AYUSH-licensed gummies and cannabis wellness products to all major cities — Delhi, Mumbai, Bengaluru, Chennai, Hyderabad, Pune, Ahmedabad and beyond. Read our cannabis delivery guide for India. Most metropolitan orders arrive in 1 to 3 business days through reputable courier partners.

Gummies in India: The Cultural Context — From Bhang to Precision Dosing

India has the world's longest unbroken tradition of consuming cannabis as an edible. The Atharva Veda (circa 1500 to 2000 BCE) lists vijaya among five sacred plants. The Charaka Samhita and Sushruta Samhita describe cannabis preparations for digestive ailments, pain, and sleep. Bhang thandai has been served at Maha Shivratri and Holi celebrations across Rajasthan, Uttar Pradesh, and Maharashtra for centuries — and remains legally sold at government-licensed bhang shops in multiple states today.

Modern AYUSH-licensed gummies are a precise, pharmaceutical-grade evolution of this cultural tradition: the same Vijaya plant, the same Ayurvedic heritage, but with standardised cannabinoid content, third-party lab verification, and formulation science that ancient preparations lacked. For Indian consumers navigating this space, the cultural familiarity is a valid grounding — this is not a foreign substance, it is a traditional Ayurvedic herb now available in a modern, dose-accurate format. Explore the full Ayurvedic tradition of Vijaya medicine in depth.

Integrating Gummies into Your Wellness Routine: Practical Protocols

A gummy is most effective as part of a consistent, goal-directed wellness protocol rather than an occasional ad-hoc supplement. Here are three practical protocols for the most common Indian use cases.

Protocol 1 — Sleep support: Take 10 to 15mg CBD-equivalent — one gummy of a standard 10mg product — 45 minutes before your target sleep time. Combine with sleep hygiene basics: no screens 30 minutes before bed, a cool dark room, and a consistent sleep-wake schedule. Track subjective sleep quality for 2 weeks before adjusting dose. See our guide on Vijaya Extract sleep mechanisms.

Protocol 2 — Anxiety management: Take 5 to 10mg CBD-equivalent in the morning with breakfast including fat. A second 5 to 10mg dose in the afternoon if anxiety peaks midday. The goal is a steady baseline level of CBD, not acute episodic dosing. Monitor using a simple 1 to 10 subjective anxiety scale daily for 3 weeks. Read the clinical evidence for cannabis and anxiety.

Protocol 3 — Pain management: Higher doses of 25 to 50mg CBD-equivalent split across the day are more commonly used for chronic pain. Take one-third of daily dose in the morning, one-third at midday, and one-third before bed. A topical CBD or Vijaya product alongside gummies can provide localised relief at the pain site. Get personalised pain management advice from our licensed doctors before starting a high-dose regimen.

The Future of Gummies in India: Market Outlook Through 2028

The Indian gummies market is positioned for significant growth through 2028. Several structural factors favour continued expansion. The AYUSH licensing pipeline is expanding: more manufacturers obtain AYUSH licences each year, broadening the product range and driving price competition that will make gummies accessible to mid-market Indian consumers at the Rs 500 to Rs 1,500 price point, down from today's Rs 2,000 to Rs 5,000.

Regulatory evolution is underway: the Delhi HC directive and growing parliamentary interest in medical cannabis reform signal that the legal framework will liberalise, potentially enabling prescription gummies for a broader range of conditions under medical supervision. FSSAI is expected to extend its 2021 hemp seed and oil approval to hemp-derived CBD in food products — a move that would allow mainstream consumer goods brands to enter the gummy space, dramatically increasing market size and consumer awareness.

THC Store is positioned at the centre of this evolution — curating AYUSH-compliant products, providing telemedicine access for prescription pathways, and educating Indian consumers through comprehensive resources. Explore our complete product guide for India to see the full range available today.

Frequently Asked Questions About Gummies in India

Are cannabis gummies legal in India?

Yes — gummies made from Vijaya Leaf Extract are legal in India when manufactured under a valid AYUSH licence as an Ayurvedic Proprietary Medicine, with THC content no more than 0.3%, and sold through a compliant retail channel. They are not legal if they contain cannabis flowers or resin (ganja or charas) or if THC exceeds 0.3%. Always verify the AYUSH licence number and CoA before purchasing. See our complete legal guide to gummies in India.

How long do gummies take to work in India?

Onset typically takes 30 to 90 minutes. India's hot climate has no significant pharmacological effect on cannabinoid onset — however, heat can degrade gummy quality if products are stored incorrectly. Store gummies in a cool, dry place away from direct sunlight, ideally below 25 degrees Celsius. If you are buying online during summer months, look for brands that use insulated packaging.

Do I need a prescription to buy gummies in India?

Not all AYUSH-licensed Vijaya Extract gummies require a prescription — many are sold as over-the-counter Ayurvedic medicines. However, higher-potency products specifically indicated for medical conditions may be prescription-designated by the manufacturer under the Drugs and Cosmetics Act. Check the label: Rx Only means prescription required. When in doubt, consult a licensed doctor who can issue a prescription and advise on the right product for your needs.

Can I take gummies with my existing medications?

CBD and other cannabinoids interact with the cytochrome P450 enzyme system in the liver — the same system that metabolises many prescription medications including blood thinners, anti-epileptics, antidepressants, and sedatives. Combining gummies with these medications without medical oversight can alter drug blood levels in clinically significant ways. Always disclose all supplements to your prescribing doctor, and book a consultation with our panel doctors if you are on any prescription medication.

What is the difference between CBD gummies and Vijaya Extract gummies?

CBD gummies contain isolated or broad-spectrum cannabidiol with THC removed. Vijaya Extract gummies contain full-spectrum Cannabis Sativa leaf extract — the complete native cannabinoid and terpene profile including trace THC no more than 0.3%. The key distinction is the entourage effect: full-spectrum Vijaya Extract products produce more pronounced effects at lower doses because cannabinoids and terpenes work synergistically. Read our full-spectrum vs. CBD-only comparison guide for a detailed analysis.

How much do gummies cost in India?

AYUSH-licensed Vijaya Extract gummies typically range from Rs 1,500 to Rs 5,000 per pack of 20 to 30 gummies, depending on cannabinoid potency and brand. Hemp wellness gummies at lower potency range from Rs 300 to Rs 1,500 per pack. Premium nano-encapsulated formulations can reach Rs 3,000 to Rs 5,000 for a 30-day supply. Compare current gummy prices on our gummies and edibles collection page.

Can I travel with gummies within India?

Travelling with AYUSH-licensed Vijaya Extract gummies within India is generally permissible when you carry the product in its original labelled packaging with the AYUSH licence number visible. Carry a copy of the brand's CoA and your doctor's prescription if applicable to facilitate any security queries. Read our complete air travel and cannabis guide for state-by-state and aviation context.

Where can I find AYUSH-licensed gummies online in India?

THC Store is one of India's leading curated platforms for AYUSH-licensed cannabis wellness products. All listed products have been reviewed for licence compliance and lab documentation before listing. Browse our Vijaya Extract collection, gummies and edibles, and CBD products to find the right format for your needs. For guided product selection, book a telemedicine consultation with our licensed doctor panel.

Sources and References

1. PMC12166629 — Enhancing cannabinoid bioavailability: a crossover study comparing a novel self-nanoemulsifying drug delivery system and a commercial oil-based formulation. PMC (PubMed Central), 2025. Confirmed significant absorption improvement with SNEDDS formulations vs. standard oil in a human crossover trial.
2. PMC10892205 — Strategies to Improve Cannabidiol Bioavailability and Drug Delivery. PMC, 2024. Reviewed lipid-based, emulsion, and encapsulation strategies for overcoming CBD's inherent low oral bioavailability.
3. PMC11595441 — CBD for anxiety meta-analysis, 2024. Statistically significant reductions in GAD-7, HAM-A, and DASS-21 anxiety scores across multiple validated instruments in 4 to 12 week trials.
4. PMC11597428 — CBD pain analgesic review, 2024. Confirmed multi-pathway analgesic activity via TRP channels, vanilloid receptors, and inflammatory cytokine modulation.
5. PMC6326553 — Shannon S. et al., Cannabidiol in Anxiety and Sleep: A Large Case Series. The Permanente Journal, 2019. 72 adults followed: 66.7 percent improved sleep scores in month one, largely sustained at months two and three with minimal adverse events.